Sanofi Weighs Takeover of US Drugmaker Insmed

Chronological Source Flow
Back

AI Fusion Summary

Sanofi SA is considering an acquisition of U.S. drugmaker Insmed Inc., according to people familiar with the matter, in what would be the largest biopharma deal in years. The potential takeover, reported by Bloomberg News and Reuters, highlights Sanofi’s strategic expansion in the biotech sector. The deal could value Insmed at several billion dollars and would mark Sanofi’s biggest pharma purchase since its 2014 acquisition of Medivation.
Community Comments
Loading updates...
0